Jane Street’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$157K Buy
130,000
+82,900
+176% +$112K ﹤0.01% 10264
2026
Q2
$104K Buy
47,100
+9,300
+25% +$24.3K ﹤0.01% 10571
2026
Q1
$88.5K Buy
+37,800
New +$89.7K ﹤0.01% 10707

Other funds holding SPRO

Jane Street's SPRO Position: Q3 2026 in Review

Jane Street reduced its Spero Therapeutics (SPRO) stake by 87% in Q3 2026, selling an estimated $187K and leaving 20,185 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #11226.

Jane Street first reported a position in SPRO in Q1 2021 and has held it in 9 quarters since. The position peaked at $369K in Q4 2025. 61 funds tracked by Wall St. Rank hold SPRO as of Q3 2026.

  • Jane Street held 20,185 shares of Spero Therapeutics worth $24.4K as of Q3 2026.
  • Jane Street sold 137,912 Spero Therapeutics shares in Q3 2026, an estimated $187K.
  • Spero Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11226 holding.
  • Jane Street first reported a position in Spero Therapeutics in Q1 2021 and has held it in 9 quarters since.
  • Jane Street's Spero Therapeutics position peaked at $369K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.